Showing results (101-110 of 110) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Immunology Letters|February 2, 2017
2003-2013, a valuable study: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in stage IV breast cancerMao Lin, Shuzhen Liang, Feng Jiang, et al.Oncology Reports|August 31, 2016
Circulating tumour cells as biomarkers for evaluating cryosurgery on unresectable hepatocellular carcinomaJian Shi, Yuan Li, Shuzhen Liang, et al.Cryobiology|May 8, 2012
Comparison of dual- and triple-freeze protocols for hepatic cryoablation in a Tibet pig modelJialiang Li, Jibing Chen, Liang Zhou, et al.Cryobiology|April 27, 2013
Cryotherapy protocols for metastatic breast cancer after failure of radical surgeryLizhi Niu, Feng Mu, Changming Zhang, et al.Pancreas|February 15, 2013
Two case reports of pilot percutaneous cryosurgery in familial multiple endocrine neoplasia type 1Jialiang Li, Changming Zhang, Jibing Chen, et al.Journal for Immunotherapy of Cancer|February 10, 2019
Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinomaMohammed Alnaggar, Yan Xu, Jingxia Li, et al.Cryobiology|June 29, 2013
Percutaneous cryoablation for stage IV lung cancer: a retrospective analysisLizhi Niu, Jibing Chen, Fei Yao, et al.Cryobiology|February 28, 2012
Comparison of dual- and triple-freeze protocols for pulmonary cryoablation in a Tibet pig modelLizhi Niu, Jialiang Li, Jibing Chen, et al.Pancreas|June 23, 2012
Pancreatic head cryosurgery: safety and efficiency in vivo--a pilot studyJialiang Li, Liang Zhou, Jibing Chen, et al.Cellular & Molecular Immunology|September 17, 2020
Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancerYan Xu, Zheng Xiang, Mohammed Alnaggar, et al.Pageof 11